R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Product Manager Oncology

Product MarketingConfirmed live in the last 24 hours
Full-timeParis, FranceNo salary listedIn-person

About the Job

Requirements

  • A Master's degree in Life Sciences (including biology or biochemistry), Medicine, or Pharmacy, combined with a Master's degree in Marketing.
  • At least 7 years of experience in pharmaceutical marketing and product management within Oncology.
  • Launch experience and launch coordination are required.
  • Several years of experience in cross-functional project management.
  • Several years of experience working with European or global teams.
  • A strong understanding of omnichannel strategies and data-driven marketing.

Responsibilities

  • Lead the strategic preparation of pipeline assets in collaboration with Business Excellence, Medical, Market Access, and European stakeholders.
  • Develop integrated launch plans that consider the healthcare environment, stakeholder landscape, and market dynamics.
  • Ensure cross-functional launch readiness across relevant functions, including Omnichannel, Business Excellence, Field Force enablement, Medical, Market Access, and material and content strategy.
  • Shape the Go-to-Market strategy in alignment with regional stakeholders.
  • Own the strategic commercialization of Oncology products in the market.
  • Develop, implement, and continuously optimize brand and marketing strategies throughout the product lifecycle.
  • Deliver marketing campaigns tailored to the French environment and targeted initiatives based on market, customer, and competitor analyses.
  • Drive product performance, including KPI tracking and identification and implementation of optimization measures.
  • Serve as a key interface between Marketing, Business Excellence, Medical Affairs, Market Access, Omnichannel Management, and the Field Force.
  • Work with Omnichannel Management to develop integrated customer journeys and data-driven engagement strategies.
  • Ensure consistent execution of marketing strategies across all channels and touchpoints.
  • Translate marketing strategies into actionable content and initiatives for the Field Force.
  • Establish and manage a continuous feedback loop between the Field Force and central Marketing.
  • Coordinate with European Marketing to support consistent portfolio and brand strategy.
  • Contribute to and apply European best practices in local implementation.
  • Align strategy, European direction, and local execution.
  • Own the commercial performance of products in collaboration with the Field Force.
  • Analyze market, customer, and competitor developments and translate insights into strategic implications for marketing and launch strategies.
  • Support the Field Force with targeted marketing and omnichannel initiatives to achieve business and revenue objectives.

Desired Qualifications

  • Extensive experience in pharmaceutical product or brand management within Oncology.
  • A strong understanding of market dynamics, the French healthcare system, customer journeys, and omnichannel marketing.
  • Ability to navigate and manage complex stakeholder structures across functions and countries.
  • Expertise in developing and executing integrated launch strategies.
  • Expertise coordinating and engaging with a cross-functional team at country and regional levels.
  • Ability to work effectively and collaboratively with the Field Force.
  • Strong analytical skills and a data-driven approach to decision-making.
  • A high degree of ownership, strategic thinking, and execution capability.
  • Strong written, verbal, and interpersonal communication skills, with a structured approach and professional presence.
  • Ability to work flexibly in a fast-growing environment, embrace change, manage ambiguity and evolving priorities, and operate within budget frames.
  • High proficiency in Microsoft Office applications, including PowerPoint, Excel, and Word, as well as other relevant business software.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs